Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

The Effects of Kinesio Taping on Hallux Valgus

13 mai 2026 mis à jour par: Muhammed Burak Örten

The Effects of Kinesio Taping on Hallux Valgus Angle, Plantar Pressure Measurements, and Foot-Related Quality of Life in Individuals With Hallux Valgus

Purpose: The purpose of this study is to evaluate the clinical, radiological, and biomechanical effects of Kinesio Taping (KT) when integrated into a standard exercise program for individuals with Hallux Valgus (HV). Hallux valgus is a progressive deformity of the first metatarsophalangeal (MTP) joint that leads to pain, functional impairment, and gait disturbances. While conservative treatments like exercises are common, the specific impact of KT on dynamic plantar pressure distribution and radiological angles requires further objective evidence.

Methods: A total of 50 participants (aged 18-65) with mild-to-moderate HV are randomized into two groups. Group 1 receives a 4-week intervention consisting of specialized Kinesio Taping applied once a week plus a daily home exercise program. Group 2 performs the same home exercise program only.

Assessments: Assessments include radiological measurements (Hallux Valgus Angle - HVA and Intermetatarsal Angle - IMA), clinical pain levels via the Visual Analog Scale (VAS), functional status via the American Orthopaedic Foot and Ankle Society (AOFAS-MTP-IP) scale, and dynamic pedobarographic analysis using the Zebris® FDM-2 system. Physical exercise capacity is also measured by the 6-Minute Walk Test (6MWT).

Aperçu de l'étude

Statut

Complété

Les conditions

Description détaillée

Background and Rationale:

Hallux valgus (HV) is a progressive musculoskeletal deformity characterized by the lateral deviation of the great toe and medial deviation of the first metatarsal. This pathology significantly impairs the first metatarsophalangeal (MTP) joint dynamics, medial longitudinal arch structure, and load-bearing mechanisms. Clinical evidence suggests that HV leads to foot pain, functional limitations, impaired balance, and an increased risk of falls. While various conservative treatments exist, Kinesio Taping (KT) has gained popularity for providing dynamic support without restricting joint range of motion. This study was conducted to evaluate the corrective, functional, and biomechanical efficacy of KT integrated into an exercise program.

Study Design:

This study utilized a prospective, randomized, controlled, and assessor-blinded design. It was conducted in accordance with the Declaration of Helsinki and approved by the local Clinical Research Ethics Committee.

Participant Selection and Randomization:

Symptomatic individuals (VAS score ≥ 3) aged 18-65 with mild-to-moderate HV (HVA 15°-40°, IMA 9°-16°) were recruited from the physical medicine and rehabilitation outpatient clinic. Participants were excluded if they had neuromuscular diseases, previous foot surgery, acute inflammatory conditions, malignancies, or skin lesions in the application area. Randomization was performed using a web-based random sequence generator (random.org), and participants were assigned to groups via sequentially numbered, opaque, sealed envelopes to ensure allocation concealment.

Intervention Protocols:

Kinesio Taping Group (Group 1): Participants received four sessions of specialized KT (Kinesio Tex Gold®) applied once a week by a certified physician. A combined "I" and "X" strip configuration was used. The "I" strip was applied from the medial proximal phalanx to the posterior calcaneus with 50% mechanical correction tension. The "X" strip was applied over the first MTP joint to provide rotational control and support the transverse arch.

Exercise Protocol: Both groups followed a standardized 4-week home exercise program (2 sets of 10 repetitions daily). The protocol included "short foot" exercises, toe spreading, modified heel raises, and isolated toe extensions, supported by visual brochures and exercise diaries.

Control Group (Group 2): Participants performed the same 4-week exercise program without any taping intervention.

Assessment and Data Collection:

Assessments were conducted at baseline and after the 4-week intervention period.

Radiological Assessment: Hallux Valgus Angle (HVA) and Intermetatarsal Angle (IMA) were measured on standard weight-bearing anteroposterior radiographs by a blinded radiologist.

Pedobarographic Analysis: Dynamic gait and static posture analyses were performed using the Zebris® FDM-2 Pressure Analysis System. Data collection included a 10-second static stance and a 20-second barefoot dynamic gait analysis. A blinded physiotherapist processed the data using 3-region (hindfoot, midfoot, forefoot) and 7-region (medial/lateral heel, midfoot, medial/internal/lateral forefoot, and toes) protocols to determine peak maximum force and pressure distribution.

Clinical and Functional Measures: Pain intensity was recorded using the Visual Analog Scale (VAS). Functional status and foot-related quality of life were evaluated using the AOFAS-MTP-IP scale. Functional exercise capacity was measured via the 6-Minute Walk Test (6MWT) in a 10-meter standardized corridor.

Statistical Analysis:

The target sample size was determined as 50 participants (25 per group) based on a power analysis (G*Power 3.1) to achieve a power of 0.95. Data analysis was performed using R software (v4.4.1). Intragroup and intergroup comparisons were conducted using parametric (Independent and Paired Samples T-tests) or non-parametric tests (Mann-Whitney U and Wilcoxon tests) depending on the normality of data distribution. Statistical significance was set at p < 0.05.

Type d'étude

Interventionnel

Inscription (Réel)

50

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

    • Kocasinan
      • Kayseri, Kocasinan, Turquie (Türkiye)
        • Kayseri City Hospital

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

  • Adulte
  • Adulte plus âgé

Accepte les volontaires sains

Non

La description

Inclusion Criteria:

  • Women and men between the ages of 18-65
  • People with mild or moderate stage hallux valgus
  • People with VAS 3 and above

Exclusion Criteria:

  • Neuromuscular diseases that limit clinical exercise, uncontrolled psychiatric diseases or cognitive-cognitive disorders
  • Patients who have received physiotherapy to the foot area in the last 6 months
  • Presence of uncontrolled systemic diseases
  • Malignancy
  • Infection
  • High fever
  • Acute inflammatory rheumatic diseases
  • Acute peripheral vascular diseases
  • Patients with previous foot surgery
  • Patients with skin lesions in the foot area
  • Patients with rheumatoid arthritis
  • Patients without cooperation and compliance
  • Patients who did not agree to participate in the study
  • Patients with foot osteoarthritis
  • Patients with gouty arthritis
  • Patients allergic to kinesio tape material
  • Patients with hallux rigidus
  • Other lower extremity alignment disorders (genu varum/valgum, developmental hip dysplasia etc.)
  • People who have a history of using foot orthosis

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Traitement
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Seul

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: Kinesio Taping and Exercise
While applying kinesio tape, individuals will also be given home exercises.
Kinesio taping for correcting hallux valgus deformity
Patients will do exercise for correcting hallux valgus deformity
Comparateur actif: Exercise
Individuals will be given only home exercises
Patients will do exercise for correcting hallux valgus deformity

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Visual Analog Scale (VAS)
Délai: 4 weeks
A type of pain scale. It has a value between 0 and 10. A decrease in the value is associated with improvement.
4 weeks
Hallux Valgus and Intermetatarsophalengeal Angle
Délai: 4 weeks
4 weeks

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Six Minute Walk Test
Délai: 4 weeks
4 weeks
Plantar Pressure Measurements
Délai: 4 weeks
4 weeks
Plantar Force Measurements
Délai: 4 weeks
4 weeks
American Orthopaedic Foot and Ankle Society Metatarsophalangeal - Interphalangeal Scale (AOFAS-MTP-IP)
Délai: 4 weeks
It has a value between 0 and 100. An increase in the value is associated with improvement.
4 weeks
Foot Rotation Degree
Délai: 4 weeks
4 weeks

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

25 décembre 2024

Achèvement primaire (Réel)

1 décembre 2025

Achèvement de l'étude (Réel)

1 décembre 2025

Dates d'inscription aux études

Première soumission

4 mai 2026

Première soumission répondant aux critères de contrôle qualité

13 mai 2026

Première publication (Réel)

15 mai 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

15 mai 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

13 mai 2026

Dernière vérification

1 mai 2026

Plus d'information

Termes liés à cette étude

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner